Bruker (BRKR) Shareholder's Equity Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.24% |
| Dec 31, 2025 | 20.48% |
| Sep 30, 2025 | 20.36% |
| Jun 30, 2025 | 14.95% |
| Mar 31, 2025 | 14.67% |
| Dec 31, 2024 | 14.40% |
| Sep 30, 2024 | 16.38% |
| Jun 30, 2024 | 15.74% |
| Mar 31, 2024 | 9.23% |
| Dec 31, 2023 | 9.03% |
| Sep 30, 2023 | 8.26% |
| Jun 30, 2023 | 9.75% |
| Mar 31, 2023 | 8.69% |
| Dec 31, 2022 | 8.94% |
| Sep 30, 2022 | 5.08% |
| Jun 30, 2022 | 5.22% |
| Mar 31, 2022 | 7.31% |
| Dec 31, 2021 | 9.37% |
| Sep 30, 2021 | 9.23% |
| Jun 30, 2021 | 8.89% |
| Mar 31, 2021 | 6.93% |
| Dec 31, 2020 | 5.86% |
| Sep 30, 2020 | 4.83% |
| Jun 30, 2020 | 3.39% |
| Mar 31, 2020 | 5.25% |
| Dec 31, 2019 | 3.51% |
| Sep 30, 2019 | 1.00% |
| Jun 30, 2019 | -0.23% |
| Mar 31, 2019 | 1.20% |
| Dec 31, 2018 | 1.26% |
| Sep 30, 2018 | 1.12% |
| Jun 30, 2018 | 1.68% |
| Mar 31, 2018 | 2.78% |
| Dec 31, 2017 | 0.66% |
| Sep 30, 2017 | 1.33% |
| Jun 30, 2017 | 3.62% |
| Mar 31, 2017 | 1.93% |
| Dec 31, 2016 | 2.09% |
| Sep 30, 2016 | 3.05% |
| Jun 30, 2016 | 1.12% |
| Mar 31, 2016 | 4.20% |
| Dec 31, 2015 | 6.80% |
| Dec 31, 2014 | 13.00% |